{"id":"https://openalex.org/W2041961964","doi":"https://doi.org/10.1097/hjh.0b013e3283314bc7","title":"Candesartan reduces the innate immune response to lipopolysaccharide in human monocytes","display_name":"Candesartan reduces the innate immune response to lipopolysaccharide in human monocytes","publication_year":2009,"publication_date":"2009-11-17","ids":{"openalex":"https://openalex.org/W2041961964","doi":"https://doi.org/10.1097/hjh.0b013e3283314bc7","mag":"2041961964","pmid":"https://pubmed.ncbi.nlm.nih.gov/19730394","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2928995"},"language":"en","primary_location":{"id":"doi:10.1097/hjh.0b013e3283314bc7","doi":"https://doi.org/10.1097/hjh.0b013e3283314bc7","is_oa":false,"landing_page_url":"https://doi.org/10.1097/hjh.0b013e3283314bc7","pdf_url":null,"source":{"id":"https://openalex.org/S115964404","display_name":"Journal of Hypertension","issn_l":"0263-6352","issn":["0263-6352","1473-5598"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hypertension","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2928995","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032449700","display_name":"Ignacio M. Larr\u00e1yoz","orcid":"https://orcid.org/0000-0003-1629-152X","observed_orcids":["https://orcid.org/0000-0003-1629-152X"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ignacio M Larrayoz","raw_affiliation_strings":["Section on Pharmacology, Division of Intramural Research Programs, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section on Pharmacology, Division of Intramural Research Programs, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031842962","display_name":"Tao Pang","orcid":"https://orcid.org/0000-0001-5420-2060","observed_orcids":["https://orcid.org/0000-0001-5420-2060"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Tao Pang","raw_affiliation_strings":["Section on Pharmacology, Division of Intramural Research Programs, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section on Pharmacology, Division of Intramural Research Programs, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032223922","display_name":"J\u00falius Benick\u00fd","orcid":"https://orcid.org/0000-0002-1941-1622","observed_orcids":["https://orcid.org/0000-0002-1941-1622"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julius Benicky","raw_affiliation_strings":["Section on Pharmacology, Division of Intramural Research Programs, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section on Pharmacology, Division of Intramural Research Programs, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065836004","display_name":"Jaroslav Pavel","orcid":"https://orcid.org/0000-0002-3898-9286","observed_orcids":["https://orcid.org/0000-0002-3898-9286"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jaroslav Pavel","raw_affiliation_strings":["Section on Pharmacology, Division of Intramural Research Programs, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section on Pharmacology, Division of Intramural Research Programs, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090140318","display_name":"Enrique S\u00e1nchez-Lemus","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Enrique S\u00e1nchez-Lemus","raw_affiliation_strings":["Section on Pharmacology, Division of Intramural Research Programs, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section on Pharmacology, Division of Intramural Research Programs, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083608744","display_name":"Juan M. Saavedra","orcid":"https://orcid.org/0000-0002-7238-9647","observed_orcids":["https://orcid.org/0000-0002-7238-9647"]},"institutions":[{"id":"https://openalex.org/I1299022934","display_name":"United States Department of Health and Human Services","ror":"https://ror.org/033jnv181","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934"]},{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210158500","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Juan M Saavedra","raw_affiliation_strings":["Section on Pharmacology, Division of Intramural Research Programs, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA","to Juan M. Saavedra, MD, Section on Pharmacology, NIMH, NIH, DHHS, 10 Center Drive, Bldg. 10, Room #2D-57, Bethesda MD 20892, USA Tel: +1 301 496 0160; fax: +1 301 402 0337; e-mail: [email\u00a0protected]","e-mail: [email\u00a0protected]","fax: +1 301 402 0337","to Juan M. Saavedra, MD, Section on Pharmacology, NIMH, NIH, DHHS, 10 Center Drive, Bldg. 10, Room #2D-57, Bethesda MD 20892, USA Tel: +1 301 496 0160"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section on Pharmacology, Division of Intramural Research Programs, National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"]},{"raw_affiliation_string":"to Juan M. Saavedra, MD, Section on Pharmacology, NIMH, NIH, DHHS, 10 Center Drive, Bldg. 10, Room #2D-57, Bethesda MD 20892, USA Tel: +1 301 496 0160; fax: +1 301 402 0337; e-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]},{"raw_affiliation_string":"e-mail: [email\u00a0protected]","institution_ids":[]},{"raw_affiliation_string":"fax: +1 301 402 0337","institution_ids":[]},{"raw_affiliation_string":"to Juan M. Saavedra, MD, Section on Pharmacology, NIMH, NIH, DHHS, 10 Center Drive, Bldg. 10, Room #2D-57, Bethesda MD 20892, USA Tel: +1 301 496 0160","institution_ids":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210158500"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5031842962","https://openalex.org/A5032449700"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210158500"],"apc_list":null,"apc_paid":null,"fwci":2.1158,"has_fulltext":false,"cited_by_count":32,"citation_normalized_percentile":{"value":0.88104314,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"27","issue":"12","first_page":"2365","last_page":"2376"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12955","display_name":"Atherosclerosis and Cardiovascular Diseases","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10371","display_name":"Immune Response and Inflammation","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/candesartan","display_name":"candesartan","score":1.0},{"id":"https://openalex.org/keywords/angiotensin-ii-type-1-receptor","display_name":"angiotensin II type 1 receptor","score":0.968999981880188},{"id":"https://openalex.org/keywords/at1-receptor-blockade","display_name":"AT1 receptor blockade","score":0.7960000038146973},{"id":"https://openalex.org/keywords/lipopolysaccharide","display_name":"lipopolysaccharide","score":0.8920000195503235},{"id":"https://openalex.org/keywords/innate-immunity","display_name":"innate immunity","score":0.8230000138282776},{"id":"https://openalex.org/keywords/monocytes","display_name":"monocytes","score":0.949999988079071},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.7289999723434448},{"id":"https://openalex.org/keywords/nf-kappab-activation","display_name":"NF-\u03baB activation","score":0.6890000104904175},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.875},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.9700000286102295},{"id":"https://openalex.org/keywords/interleukin-1beta","display_name":"IL-1\u03b2","score":0.9940000176429749},{"id":"https://openalex.org/keywords/oxidized-ldl-receptor","display_name":"oxidized LDL receptor","score":0.7670000195503235},{"id":"https://openalex.org/keywords/reactive-oxygen-species","display_name":"reactive oxygen species","score":0.8529999852180481},{"id":"https://openalex.org/keywords/cd14","display_name":"CD14","score":0.7689999938011169},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.6100000143051147}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8905662298202515},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.871477484703064},{"id":"https://openalex.org/C2780036600","wikidata":"https://www.wikidata.org/wiki/Q415970","display_name":"Candesartan","level":4,"score":0.8478901982307434},{"id":"https://openalex.org/C2778754761","wikidata":"https://www.wikidata.org/wiki/Q421804","display_name":"Lipopolysaccharide","level":2,"score":0.7330701947212219},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5528346300125122},{"id":"https://openalex.org/C2781184567","wikidata":"https://www.wikidata.org/wiki/Q107244","display_name":"Monocyte","level":2,"score":0.48642826080322266},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4819638431072235},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.13702046871185303},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.12292048335075378},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D001562","descriptor_name":"Benzimidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001713","descriptor_name":"Biphenyl Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007113","descriptor_name":"Immunity, Innate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007113","descriptor_name":"Immunity, Innate","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D008070","descriptor_name":"Lipopolysaccharides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009000","descriptor_name":"Monocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009000","descriptor_name":"Monocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013777","descriptor_name":"Tetrazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015870","descriptor_name":"Gene Expression","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017382","descriptor_name":"Reactive Oxygen Species","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D044140","descriptor_name":"Receptor, Angiotensin, Type 1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D044140","descriptor_name":"Receptor, Angiotensin, Type 1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D044140","descriptor_name":"Receptor, Angiotensin, Type 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D047228","descriptor_name":"Angiotensin II Type 1 Receptor Blockers","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1097/hjh.0b013e3283314bc7","doi":"https://doi.org/10.1097/hjh.0b013e3283314bc7","is_oa":false,"landing_page_url":"https://doi.org/10.1097/hjh.0b013e3283314bc7","pdf_url":null,"source":{"id":"https://openalex.org/S115964404","display_name":"Journal of Hypertension","issn_l":"0263-6352","issn":["0263-6352","1473-5598"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hypertension","raw_type":"journal-article"},{"id":"pmid:19730394","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19730394","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of hypertension","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2928995","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2928995","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"J Hypertens","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:2928995","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/2928995","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"J Hypertens","raw_type":"Text"},"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4712338446","display_name":null,"funder_award_id":"Z99 MH999999","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G6771071427","display_name":"Mechanistic studies on stress, brain inflammation and neuroprotection","funder_award_id":"ZIAMH002762","funder_id":"https://openalex.org/F4320337346","funder_display_name":"National Institute of Mental Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337346","display_name":"National Institute of Mental Health","ror":"https://ror.org/04xeg9z08"},{"id":"https://openalex.org/F4320338421","display_name":"NHLBI Division of Intramural Research","ror":"https://ror.org/023ny1p48"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":63,"referenced_works":["https://openalex.org/W1585390661","https://openalex.org/W1592720347","https://openalex.org/W1615242172","https://openalex.org/W1673084462","https://openalex.org/W1907915877","https://openalex.org/W1967291007","https://openalex.org/W1969773497","https://openalex.org/W1970216382","https://openalex.org/W1976763513","https://openalex.org/W1982270701","https://openalex.org/W1985558958","https://openalex.org/W1985578820","https://openalex.org/W1988206467","https://openalex.org/W1988334706","https://openalex.org/W1995459470","https://openalex.org/W1995753814","https://openalex.org/W1999630001","https://openalex.org/W2000178052","https://openalex.org/W2011079644","https://openalex.org/W2011643486","https://openalex.org/W2012719211","https://openalex.org/W2017697454","https://openalex.org/W2019767570","https://openalex.org/W2021336399","https://openalex.org/W2021345753","https://openalex.org/W2027589113","https://openalex.org/W2047512700","https://openalex.org/W2048900216","https://openalex.org/W2050991399","https://openalex.org/W2052969372","https://openalex.org/W2053647200","https://openalex.org/W2060493797","https://openalex.org/W2063638544","https://openalex.org/W2064711537","https://openalex.org/W2069898576","https://openalex.org/W2071665518","https://openalex.org/W2083379162","https://openalex.org/W2090921095","https://openalex.org/W2094712136","https://openalex.org/W2101363646","https://openalex.org/W2106015379","https://openalex.org/W2113671760","https://openalex.org/W2114722474","https://openalex.org/W2119869567","https://openalex.org/W2120833100","https://openalex.org/W2121796458","https://openalex.org/W2124921305","https://openalex.org/W2128651238","https://openalex.org/W2133469256","https://openalex.org/W2137480747","https://openalex.org/W2146355738","https://openalex.org/W2149411404","https://openalex.org/W2153194422","https://openalex.org/W2158102122","https://openalex.org/W2159580160","https://openalex.org/W2165626477","https://openalex.org/W2167260676","https://openalex.org/W2169025417","https://openalex.org/W2209434885","https://openalex.org/W2223421358","https://openalex.org/W2320704296","https://openalex.org/W2404272324","https://openalex.org/W6687810015"],"related_works":["https://openalex.org/W2130703143","https://openalex.org/W2355205542","https://openalex.org/W2048587489","https://openalex.org/W2078034806","https://openalex.org/W2531596190","https://openalex.org/W2292110255","https://openalex.org/W2943696388","https://openalex.org/W2736609939","https://openalex.org/W2030221708","https://openalex.org/W2374376692"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Inhibition":[1],"of":[2,126,135,162,188,197,232,236],"angiotensin":[3,107],"II":[4,69,108],"receptor":[5,19,66,70,79,210],"type":[6],"1":[7,61],"(AT1)":[8],"reduces":[9,218],"chronic":[10],"inflammation":[11],"associated":[12],"with":[13,54,58],"hypertension.":[14],"We":[15,33,191],"asked":[16],"whether":[17],"AT1":[18,65,104,209],"inhibition":[20],"would":[21],"reduce":[22],"the":[23,123,127,130,138,150,160,163,169,178,186,194,219],"innate":[24,220],"inflammatory":[25,83,112,246],"response":[26,222],"induced":[27,181],"by":[28,43,75,81,89,95,182,205],"bacterial":[29],"lipopolysaccharide":[30],"(LPS).":[31],"METHODS:":[32],"used":[34],"unstimulated":[35],"human":[36,226],"circulating":[37,227],"monocytes":[38,99],"obtained":[39],"from":[40],"healthy":[41],"donors":[42],"counterflow":[44],"centrifugal":[45],"elutriation.":[46],"Monocytes":[47],"were":[48],"studied":[49,88],"in":[50,199,225,240,244],"vitro":[51],"after":[52],"incubation":[53],"LPS":[55,131,224],"(50":[56],"ng/ml)":[57],"and":[59,78,92,106,147,149,174,177],"without":[60,184],"mumol/l":[62],"candesartan,":[63],"an":[64],"blocker.":[67],"Angiotensin":[68],"mRNA":[71,85,114],"expression":[72,86,115,125],"was":[73,87],"determined":[74],"reverse":[76,90],"transcriptase-PCR":[77,91],"binding":[80],"autoradiography;":[82],"factor":[84,113,143,165,172],"cytokine":[93,117],"release":[94],"ELISA.":[96],"RESULTS:":[97],"Human":[98],"did":[100,109],"not":[101,110,238],"express":[102],"detectable":[103],"receptors,":[105],"induce":[111],"or":[116],"release.":[118],"However,":[119],"candesartan":[120,158,198,216,233],"substantially":[121],"reduced":[122,159],"LPS-induced":[124],"mRNAs":[128],"for":[129],"recognition":[132],"protein":[133],"cluster":[134],"differentiation":[136],"14,":[137],"proinflammatory":[139],"cytokines":[140],"tumor":[141,170],"necrosis":[142,171],"alpha,":[144],"interleukin-1":[145],"beta":[146],"interleukin-6":[148,175],"lectin-like":[151],"oxidized":[152],"low-density":[153],"lipoprotein":[154],"receptor.":[155],"In":[156],"addition,":[157],"activation":[161],"nuclear":[164],"kappa":[166],"B":[167],"pathway,":[168],"alpha":[173],"secretion,":[176],"ROS":[179],"formation":[180],"LPS,":[183],"affecting":[185],"secretion":[187],"interleukin-10.":[189],"CONCLUSION:":[190],"hypothesize":[192],"that":[193,215],"anti-inflammatory":[195,230],"effects":[196,231],"these":[200],"cells":[201],"are":[202],"likely":[203],"mediated":[204],"mechanisms":[206],"unrelated":[207],"to":[208,223],"blockade.":[211],"Our":[212],"results":[213],"demonstrate":[214],"significantly":[217],"immune":[221],"monocytes.":[228],"The":[229],"may":[234],"be":[235],"importance":[237],"only":[239],"hypertension":[241],"but":[242],"also":[243],"other":[245],"disorders.":[247]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}